JS207 injection +docetaxel: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

2

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 2 1

Conditions being studied

Condition	Trials
Advanced NSCLC	1
Lung cancer	1

Recruiting trials involving JS207 injection +docetaxel

Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
NCT06924606 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 18 locations

Common questions

How many recruiting trials involve JS207 injection +docetaxel?

1 recruiting trial across 2 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.